Poziotinib Inhibits HER2-Mutant-Driven Therapeutic Resistance and Multiorgan Metastasis in Breast CancerCANCER RESEARCHIF16.62022-06-2312OAAI
Distinct HER2 allele specific therapeutic response and preclinical efficacy of poziotinib in metastatic ER+HER2 mutant breast cancerCANCER RESEARCHIF16.62022-02-150PRE
Mismatch repair deficiency predicts response to HER2 blockade in HER2-negative breast cancerNATURE COMMUNICATIONSIF15.72021-05-1913OAAI
E2F1 regulates testicular descent and controls spermatogenesis by influencing WNT4 signalingDEVELOPMENTIF3.62021-01-1316OA
Docosahexanoic acid's modulation of survival and invasion is associated with altered CCL20/CCR6 chemokine levels and signaling in hyperplastic, DCIS and metastatic breast cancer cell linesCANCER RESEARCHIF16.62015-05-010PRE
Verification of Dual Factors theory with eye movements during a matchstick arithmetic insight problemTHINKING SKILLS AND CREATIVITYIF4.52014-09-0113PREAI
Anethole suppressed cell survival and induced apoptosis in human breast cancer cells independent of estrogen receptor statusPHYTOMEDICINEIF8.32012-06-0156PREAI
In vitro modeling for breast cancer prevention - omega-3 ethyl esters functioning as preventive agents in 21T series modelsCANCER RESEARCHIF16.62012-04-010PRE
Omega-3 ethyl esters: Differential involvement of NF-kB in suppressing cell viability of genetically diverse breast cancer cell linesCANCER RESEARCHIF16.62011-04-010PRE